Clinical Trials Logo

Filter by:
NCT ID: NCT05892055 Withdrawn - Clinical trials for Functional Abdominal Pain Syndrome

Brain Mechanisms of Attention and Pain in Youth With FAPD

Start date: February 28, 2019
Phase:
Study type: Observational

The objectives of this study are to identify neural mechanisms of increased pain in pediatric FAPD and examine mechanisms of disrupted attention in the presence of induced pain. The overarching goal is to determine whether youth with FAPD process pain differently than healthy youth and to identify the brain areas involved.

NCT ID: NCT05883228 Withdrawn - Physician's Role Clinical Trials

Anesthesiologist Perspectives/Opinions/Ethics on Intraoperative/Intraprocedural Code Status and Intraoperative/Intraprocedural Code Status Management Plans

AnesOpIntraDNR
Start date: September 2023
Phase:
Study type: Observational

This survey aims to understand anesthesiologists' opinions on intraoperative/intraprocedural code status management (like for example, Do Not Resuscitate (DNR)) in various patient scenarios. Your valuable input will help us better understand current practices and preferences in the field. The understanding of the perspectives of ASA (American Society of Anesthesiologists) member staff anesthesiologists and staff anesthesiologists in general on this matter is of critical importance in the field of anesthesiology as the intraoperative/intraprocedural patient population continues to collectively get older and sicker in the future. Goal/Aims: The goal of this survey is to ascertain the perspectives of all active ASA member staff anesthesiologists and staff anesthesiologists in general on the matters of intraoperative/intraprocedural code status and intraoperative/intraprocedural code status management plans

NCT ID: NCT05853731 Withdrawn - Cardiac Surgery Clinical Trials

The Effect of Light Therapy on Post-Surgical Pain

Start date: December 2023
Phase: N/A
Study type: Interventional

Researchers aim to demonstrate that the use of phototherapy is feasible and may reduce acute postoperative pain based on recent literature. The primary objective is to demonstrate that displaying light-emitting diodes [LED] can be achieved in the ICU setting in after cardiac surgery.

NCT ID: NCT05848843 Withdrawn - Lung Cancer Clinical Trials

A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations

Start date: April 25, 2023
Phase: Phase 1
Study type: Interventional

To find a recommended dose of the combination of adagrasib and durvalumab that can be given to patients with cancers that have a KRAS G12C mutation.

NCT ID: NCT05845008 Withdrawn - Orthodontic Pain Clinical Trials

A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain

Start date: January 15, 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of a fixed combination of acetaminophen/naproxen sodium when administered as multiple doses over a period of up to 10 days in adolescents 12 to below 17 years of age with post-procedure orthodontic pain.

NCT ID: NCT05840536 Withdrawn - Clinical trials for Acute Decompensated Heart Failure

Combination Diuretic Therapy for Acute Decompensated Heart Failure

COMBIND-HF
Start date: May 2014
Phase: Phase 4
Study type: Interventional

Patients with heart failure are often admitted to the hospital because they have accumulated excessive amounts of fluid, they become short of breath and congested with fluid. Removing the excess fluid is necessary to improve the patients symptoms and reduce the risk of being re-admitted to the hospital. Diuretics ("water pills") are often given through an IV to accelerate the fluid removal. Furosemide is commonly used for fluid removal, however some patients do not respond well to the medication. There are other diuretics available that can work in conjunction with furosemide and increase the rate of fluid removal. The other "water pills" have slightly different mechanisms of action in the body compared to furosemide and when combined they may increase fluid removal. The investigators hypothesize that adding chlorothiazide to furosemide will result in quicker and more effective fluid removal in heart failure patients.

NCT ID: NCT05834062 Withdrawn - Obesity, Adolescent Clinical Trials

Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity

Start date: October 17, 2023
Phase: Phase 2
Study type: Interventional

This study will test the use of phentermine and topiramate compared with placebo in helping adolescents who are at high risk for developing obesity to lose weight

NCT ID: NCT05829200 Withdrawn - TCD Clinical Trials

Transcranial Doppler(TCD) Evaluation of High Intensity Transient Signals and Carotid Disease

TCD
Start date: July 15, 2013
Phase: N/A
Study type: Interventional

Carotid Disease causes 10% of strokes. The Investigators are attempting to investigate the use of Transcranial Doppler to see if this is and effective, efficient, and/or valid way to identify individuals at highest risk for thromboembolic events from carotid disease. The plan is to plot the number of high intensity transient transcranial doppler signals with the category of patient (asymptomatic, symptomatic, and actively symptomatic) and evaluate if a relationship exists. The Investigators hypothesize that a linear relationship exists in that the higher the number of HITS the more symptomatic the patient. If results demonstrate the numbers of HITS correlate with the severity of disease this could potentially identify asymptomatic patients having subclinical symptoms who would benefit from a more urgent surgical intervention versus the current standard of care of elective intervention.

NCT ID: NCT05828277 Withdrawn - Clinical trials for Metastatic Solid Tumor

A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients

Start date: July 28, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase 1 study to evaluate the effect of moderate or severe hepatic impairment on the PK of repotrectinib in patients with advanced cancer.

NCT ID: NCT05821582 Withdrawn - Colorectal Cancer Clinical Trials

Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens

Start date: March 27, 2023
Phase:
Study type: Observational

The primary objective of the study is to determine whether there is a correlation between the intestinal side effects of chemotherapy treatment and the expression/activity profiles of glucuronidase enzymes in the stool microbiome of the target patient population.